 Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly preparation-free screening test to detect polyps before they transform into colorectal cancer, today announced financial results for the fourth quarter and full year ended December 31, 2019. 